Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 16, 1998JNCI Journal of the National Cancer InstituteOpen Access

erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ATAnn D. ThorDBDonald A. BerryDBDaniel R. Budman

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thor et al. (1998) studied this question.

synapsesocial.com/papers/6a0cd465c031bbff4134c4cchttps://doi.org/10.1093/jnci/90.18.1346
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Understanding Adjuvant Chemotherapy for Breast Cancer1994 · 14 citations
  2. 2Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.1989 · 164 citations
  3. 3Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer1988 · 937 citations
  4. 4Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma1994 · 582 citations
  5. 5The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast Cancer1996 · 442 citations